Diagnosis & Treatment Blogs

The point at which lung cancer is diagnosed plays a key role in treatment and survival. The average 5-year survival rate for lung cancer diagnosed while still localized (stage I)

Participating in a clinical trial gives patients the ability to try the newest treatments that otherwise are not available. There are many ongoing clinical trials testing new lung cancer treatments, including targeted therapies, chemotherapy, radiation therapy, and immunotherapy, alone and in combination.

Paul K. Paik, MD, medical oncologist and researcher at Memorial Sloan Kettering Cancer Center and a member of LUNGevity’s Scientific Advisory Board, sat down to talk about what squamous cell lung cancer is and where we stand with treatment options for this disease.

Communication is critical to a positive doctor-patient relationship. Knowing the right questions to ask helps ensure you leave your appointments with the information and answers

For World Cancer Day this year, the Union for International Cancer Control presents the #CloseTheCareGap initiative. February 4, 2023 will be a day focused on promoting equity in

While targeted therapies have emerged in the past decade to improve treatment of non-small cell lung cancer (NSCLC) with some types of driver mutations (such as EGFR and ALK), lung

On June 1st, 2022, LUNGevity Foundation hosted a Facebook Live to discuss our manuscript titled “ The 2021 Global Lung Cancer Therapy Landscape” published in the Journal of

Palliative care, or supportive care, often misunderstood as only end-of-life care, improves patients' quality of life while undergoing treatment. The goal of palliative care is to

For people with lung cancer, one of the first steps in navigating their diagnosis comes from understanding what their lung cancer stage means for the future of their treatment.

On February 10, 2022, the Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Decision to expand reimbursement for lung cancer screening with low-density

Personalized medicine, in which the molecular profile of each patient’s tumor helps customize the course of treatment, has been useful in treating many types of cancer, including

Historically, surgery has been the most effective treatment for patients with early-stage non-small cell lung cancer (NSCLC). While technological improvements, such as the